p53 mutations occur very frequently in human cancer. Besides abrogating the tumour suppressive functions of wild-type p53, many of those mutations also acquire oncogenic gain-of-function activities. Augmentation of proteasome activity is now reported as a common gain-of-function mechanism shared by different p53 mutants, which promotes cancer resistance to proteasome inhibitors.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Targeting poor proteasomal function with radioiodine eliminates CT26 colon cancer stem cells resistant to bortezomib therapy
Scientific Reports Open Access 31 August 2020
-
Reporter PET Images Bortezomib Treatment-Mediated Suppression of Cancer Cell Proteasome Activity
Scientific Reports Open Access 16 August 2018
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Olivier, M. & Taniere, P. Curr. Opin. Oncol. 23, 88–92 (2011).
Rotter, V. Proc. Natl Acad. Sci. USA 80, 2613–2617 (1983).
Oren, M. & Rotter, V. Cold Spring Harb. Perspect. Biol. 2, a001107 (2010).
Freed-Pastor, W. A. & Prives, C. Genes Dev. 26, 1268–1286 (2012).
Kato, S. et al. Proc. Natl Acad. Sci. USA 100, 8424–8429 (2003).
Zhu, J. et al. Nature 525, 206–211 (2015).
Walerych, D. et al. Nat. Cell Biol. 18, 897–909 (2016).
DeNicola, G. M. et al. Nature 475, 106–109 (2011).
Tung, M. C. et al. Oncotarget 6, 41692–41705 (2015).
Hershko, A. & Ciechanover, A. Annu. Rev. Biochem. 67, 425–479 (1998).
Vogelstein, B. et al. Science 339, 1546–1558 (2013).
Deshaies, R. J. BMC Biol. 12, 94 (2014).
Richardson, P. G. et al. N. Engl. J. Med. 352, 2487–2498 (2005).
O'Connor, O. A. et al. J. Clin. Oncol. 23, 676–684 (2005).
Brosh, R. & Rotter, V. Nat. Rev. Cancer 9, 701–713 (2009).
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Oren, M., Kotler, E. p53 mutations promote proteasomal activity. Nat Cell Biol 18, 833–835 (2016). https://doi.org/10.1038/ncb3392
Published:
Issue Date:
DOI: https://doi.org/10.1038/ncb3392